Eleftherios Mylonakis
- Aging top 0.1%
- Genetics, Aging, and Longevity in Model Organisms 26
- Applied Microbiology and Biotechnology top 0.05%
- Infectious Diseases top 0.05%
- Antifungal resistance and susceptibility 109
- Antimicrobial Resistance in Staphylococcus 52
- Molecular Medicine top 0.1%
- Antibiotic Resistance in Bacteria 29
- Microbiology top 0.1%
- Antimicrobial Peptides and Activities 36
-
- Fungal Infections and Studies 73
-
- Bacterial Identification and Susceptibility Testing 31
-
- Bacterial biofilms and quorum sensing 30
- Co-authors
- Stephen B. CalderwoodBeth Burgwyn FuchsFrederick M. AusubelPanayiotis D. ZiakasHerman CarneiroAnton Y. PelegMarios ArvanitisIoannis M. Zacharioudakis
- Journals
- PLoS ONE (30 papers)Clinical Infectious Diseases (22 papers)Antimicrobial Agents and Chemotherapy (19 papers)
- Partner nations
- United StatesGreeceBrazil
In The Last Decade
Eleftherios Mylonakis
423 papers receiving 22.0k citations
Hit Papers
Peers
Comparison fields: 5 of 201
- Aging 1.0k
- Applied Microbiology and Biotechnology 1.1k
- Infectious Diseases 9.3k
- Molecular Medicine 1.8k
- Microbiology 1.7k
Countries citing papers authored by Eleftherios Mylonakis
This map shows the geographic impact of Eleftherios Mylonakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleftherios Mylonakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleftherios Mylonakis more than expected).
Fields of papers citing papers by Eleftherios Mylonakis
This network shows the impact of papers produced by Eleftherios Mylonakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleftherios Mylonakis. The network helps show where Eleftherios Mylonakis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eleftherios Mylonakis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 9 | |
| 4 | 2024 | 8 | |
| 5 | 2023 | 11 | |
| 6 | 2022 | 22 | |
| 7 | 2020 | 35 | |
| 8 | 2020 | 48 | |
| 9 | 2020 | 19 | |
| 10 | 2020 | 65 | |
| 11 | 2020 | 29 | |
| 12 | 2018 | 7 | |
| 13 | 2017 | 62 | |
| 14 | 2016 | 269 | |
| 15 | 2016 | 13 | |
| 16 | 2009 | 327 | |
| 17 | 2008 | 144 | |
| 18 | 2002 | 248 | |
| 19 | 2001 | 445 | |
| 20 | When to suspect and how to monitor babesiosis. | 2001 | 42 |
About Eleftherios Mylonakis
Eleftherios Mylonakis is a scholar working on Aging, Infectious Diseases and Microbiology, having authored 430 papers that have together received 22.5k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (109 papers), Fungal Infections and Studies (73 papers), Antimicrobial Resistance in Staphylococcus (52 papers), Antimicrobial Peptides and Activities (36 papers), Bacterial Identification and Susceptibility Testing (31 papers), Bacterial biofilms and quorum sensing (30 papers), Antibiotic Resistance in Bacteria (29 papers) and Genetics, Aging, and Longevity in Model Organisms (26 papers). The work is most often cited by research in Aging (1.0k citations), Applied Microbiology and Biotechnology (1.1k citations) and Infectious Diseases (9.3k citations). Eleftherios Mylonakis has collaborated with scholars based in United States, Greece and Brazil. Frequent co-authors include Stephen B. Calderwood, Beth Burgwyn Fuchs, Frederick M. Ausubel, Panayiotis D. Ziakas, Herman Carneiro, Anton Y. Peleg, Marios Arvanitis, Ioannis M. Zacharioudakis, Jeffrey J. Coleman and Fainareti N. Zervou. Their work appears in journals such as PLoS ONE, Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy, Open Forum Infectious Diseases and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.